Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

COVID-19 Pneumonia: early-phase trial registry

3 of 6 indexed COVID-19 Pneumonia trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count

COVID-19 Pneumonia: 6 US clinical trials tracked, 3 recruiting.

COVID-19 Pneumonia is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is The Geneva Foundation, running 2 of these trials.

Enrollment posture brief

Registry condition covid-19-pneumonia

OPEN 3 | RECR 50% | LATE 0 | EARLY 1 | RANK #2866 | SPON 2

Nearest open-share peer: Achalasia (50% recruiting · 8 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%COVID-19 Pneumonia (this)50%
Open-enrollment share among volume-matched conditions near COVID-19 Pneumonia

COVID-19 Pneumonia lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for COVID-19 Pneumonia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. COVID-19 Pneumonia is recruiting above its size-band peers.

    3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates COVID-19 Pneumonia research.

    The Geneva Foundation accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical COVID-19 Pneumonia enrolment sits around 300 participants.

    Median target enrolment is 300 among the 6 trials that report a genuine target (sentinel values excluded). 2 of those (33.3%) plan for fewer than 100 participants.

  4. COVID-19 Pneumonia research leans observational.

    2 interventional and 4 observational studies make up this index (33.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on COVID-19 Pneumonia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

No Intervention Used Other
1 trials
imPulse™ Systems (Una and TOR) infrasound-to-ultrasound e-stethoscope Device
1 trials
A&M Breathalyzer PROTECT Kiosk Device
1 trials
Balanced amino acid Dietary supplement
1 trials
β-hydroxy β-methyl butyrate (HMB) enriched amino acid Dietary supplement
1 trials
Questionnaire Diagnostic test
1 trials
6-minute walk test Diagnostic test
1 trials
Echocardiogram Diagnostic test
1 trials

US sites by state

Facility locations filed on COVID-19 Pneumonia trials. A trial with sites in several states counts in each.

Texas 2 trials
Ohio 1 trials
New York 1 trials
Illinois 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this COVID-19 Pneumonia page

6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This COVID-19 Pneumonia condition card totals 6 registered trials; most-linked intervention No Intervention Used; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.